Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies.
- 1 May 1988
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 6 (5), 786-792
- https://doi.org/10.1200/jco.1988.6.5.786
Abstract
To evaluate the potential effect of patient selection on chemotherapy trials for patients with advanced germ cell tumors (GCT), four sets of eligibility criteria for poor risk trials were compared in 118 patients. A significant difference was found in the number of patients designated poor risk by the various criteria (P < .005). Disagreement in the risk assignment by the various selection criteria was seen in 44% of patients. Initial complete response (CR) rates in patients designated poor risk by the various criteria ranged from 38% to 62%. Initial CR rates as high as 94% were seen in patients considered to be poor risk by one set of criteria, but good risk by another. Substantial differences in sensitivity, specificity, overall predictive value, and survival distributions were observed for the various selection criteria. Randomized trials will be necessary to reduce the influence of eligibility criteria on trial outcome and conclusions.This publication has 8 references indexed in Scilit:
- Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.Journal of Clinical Oncology, 1987
- VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.Journal of Clinical Oncology, 1986
- Prognostic factors for favorable outcome in disseminated germ cell tumors.Journal of Clinical Oncology, 1986
- Chemotherapy of extragonadal germ cell tumors.Journal of Clinical Oncology, 1985
- Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.Journal of Clinical Oncology, 1985
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- FURTHER ADVANCES IN THE MANAGEMENT OF MALIGNANT TERATOMAS OF THE TESTIS AND OTHER SITESThe Lancet, 1983
- MULTIVARIATE-ANALYSIS OF PROGNOSTIC VARIABLES IN PATIENTS WITH METASTATIC TESTICULAR CANCER1983